(0.26%) 5 535.75 points
(0.27%) 39 574 points
(0.26%) 19 979 points
(0.63%) $82.05
(-1.73%) $2.56
(0.34%) $2 347.50
(0.14%) $29.60
(-0.64%) $995.50
(-0.26%) $0.931
(-0.31%) $10.64
(-0.18%) $0.789
(2.09%) $87.52
Live Chart Being Loaded With Signals
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America...
Stats | |
---|---|
Šios dienos apimtis | 428 327 |
Vidutinė apimtis | 244 208 |
Rinkos kapitalizacija | 7.81B |
EPS | $13.46 ( Q1 | 2024-05-08 ) |
Kita pelno data | ( $2.12 ) 2024-08-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-25.55 (Sector) 49.64 (Industry) 37.79 |
ATR14 | $0.296 (0.11%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-16 | Wright Dara | Buy | 502 | Bio-Rad A Common Stock |
2023-12-16 | Wright Dara | Sell | 174 | Bio-Rad A Common Stock |
2023-12-16 | Wright Dara | Sell | 502 | Restricted Stock Units |
2023-12-05 | Schwartz Steven D | Buy | 49 | Bio-Rad B Common Stock |
2023-12-05 | Schwartz Steven D | Buy | 49 | Bio-Rad B Common Stock |
INSIDER POWER |
---|
-17.63 |
Last 100 transactions |
Buy: 98 565 | Sell: 137 343 |
Tūris Koreliacija
Bio Rad Laboratories Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
RSF | 0.901 |
DLR-PJ | 0.887 |
PSA-PG | 0.887 |
HIO | 0.887 |
ATIP | 0.884 |
PSA-PF | 0.882 |
PSA-PR | 0.88 |
PSA-PS | 0.879 |
AMH-PG | 0.877 |
PSA-PJ | 0.876 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
AIRC | -0.921 |
ACB | -0.868 |
CAG | -0.836 |
WPM | -0.835 |
DBB | -0.834 |
SIL | -0.833 |
FSM | -0.83 |
ASA | -0.82 |
MODN | -0.811 |
CMCM | -0.804 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Bio Rad Laboratories Inc Koreliacija - Valiuta/Žaliavos
Bio Rad Laboratories Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $2.67B |
Bruto pelnas: | $1.43B (53.58 %) |
EPS: | $-21.82 |
FY | 2023 |
Pajamos: | $2.67B |
Bruto pelnas: | $1.43B (53.58 %) |
EPS: | $-21.82 |
FY | 2022 |
Pajamos: | $2.80B |
Bruto pelnas: | $1.57B (55.93 %) |
EPS: | $-121.79 |
FY | 2021 |
Pajamos: | $2.92B |
Bruto pelnas: | $1.64B (56.14 %) |
EPS: | $142.63 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Bio Rad Laboratories Inc
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.